Depression after smoking cessation: Case reports

Journal of Clinical Psychiatry

Volumn 57, Issue 10, 1996, Pages 467-469

  Stage, Kurt B ^a,b,c   Glassman, Alexander H ^a,b   Covey, Lirio S ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University ^*  (United States)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; FLUOXETINE; ISOCARBOXAZID; LIOTHYRONINE; LITHIUM; NICOTINE; PHENELZINE; TRANYLCYPROMINE;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; COUNSELING; DEPRESSION; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; SMOKING CESSATION;

EID: 0029830539     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v57n1005     Document Type: Article

References (15)

1. Covey LS, Glassman AH, Stetner F. Depression and depressive symptoms in smoking cessation. Compr Psychiatry 1990;31:350-354
2. Glassman AH. Cigarette smoking: implications for psychiatric illness. Am J Psychiatry 1993;150:546-553
3. Flanagan J, Maany I. Smoking and depression [letter]. Am J Psychiatry 1982;139:541
4. Glassman AH, Covey LS, Dalack GW, et al. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther 1993;54:670-679
5. Hajek P. Individual differences in difficulty quitting smoking. British Journal of Addiction 1991;86:555-558
6. Covey LS, Glassman AH. New approaches to smoking cessation. Drug Therapy 1990;20:55-61
7. Glassman AH, Stetner F, Walsh BT, et al. Heavy smokers, smoking cessation, and clonidine: results of a double-blind, randomized trial. JAMA 1988;259:2863-2866
8. Hall SM, Munoz RF, Reus VI. Depression and smoking treatment: a clinical trial of an affect regulation treatment. NIDA Res Monogr 1992; 119:326
9. Covey LS, Glassman AH, Stetner F. Major depression following smoking cessation. Am J Psychiatry. In press
10. Goldstein A. Criteria of a pharmacologic withdrawal syndrome [letter]. Arch Gen Psychiatry 1987;44:392
11. Weeke A. Causes of death in manic-depressives. In: Schou M, Stromgren E, eds. Origin, Prevention and Treatment of Affective Disorders. London, England: Academic Press; 1979:289-299
12. Zilber N, Schufman N, Leraer Y. Mortality among psychiatric patients: the groups at risk. Acta Psychiatr Scand 1989;79:248-256
13. Anda RF, Williamson DF, Jones D, et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology 1993;4:285-294
14. Ferry LH, Burchette RJ. Evaluation of bupropion versus placebo for treatment of nicotine dependence. In: New Research Program and Abstracts of the Proceedings of the American Psychiatric Association; May 21-26, 1994; Philadelphia, Pa. Abstract NR554: 199-200
15. Hall SM. New directions in medications for the treatment of tobacco dependence. Presented at the 2nd annual conference of the Society for Research on Nicotine and Tobacco; March 15-17, 1996; Washington, DC